Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

NexPoint Real Estate Finance Projections for 1Q 2024

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
Real Estate Investment Trading online
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

NexPoint Real Estate Finance has shared projections for the initial quarter of 2024, estimating an Earnings per Diluted Share range of $(0.50)-$(0.40). This forecast hints at a possible per-share deficit falling within this designated interval for the start of 2024. Moreover, the firm disclosed its financial outcomes for the last quarter of 2023, with the 1Q 2024 Earnings per Diluted Share guidance positioned at $(0.45) at the midpoint. These details offer a glimpse into the company’s financial standing and anticipated outcomes for the forthcoming quarters.

NREF Stock Shows Positive Momentum on February 29, 2024 with Strong Start and 2.24% Price Increase

On February 29, 2024, NREF stock showed positive momentum as it traded in the middle of its 52-week range and below its 200-day simple moving average. The stock opened at $13.67, which was $0.30 higher than its previous close, indicating a strong start to the trading day. Throughout the day, NREF shares continued to climb, with a price increase of $0.30 since the market last closed. This represented a 2.24% rise in the stock price, showing that investors were optimistic about the company’s performance.

NREF Stock Performance Analysis: Mixed Results on February 29, 2024

On February 29, 2024, NREF stock experienced mixed performances based on the financial data provided by CNN Money. The total revenue for the company was reported at $114.17 million for the past year, which showed a 16.59% increase compared to the previous year. However, the total revenue for the third quarter of the year was $27.00 million, indicating a 5.0% decrease compared to the previous quarter.

The net income for NREF was $6.75 million for the past year, reflecting an 84.34% decrease compared to the previous year. The net income for the third quarter, on the other hand, was reported at -$14.68 million, showing a significant 321.66% decrease compared to the previous quarter.

Earnings per share (EPS) for NREF were $0.22 for the past year, which represented a 94.39% decrease compared to the previous year. The EPS for the third quarter was reported at -$0.90, indicating a substantial 373.95% decrease compared to the previous quarter.

Overall, the financial performance of NREF on February 29, 2024, showed a mixed trend with an increase in total revenue compared to the previous year but a decrease in net income and EPS both compared to the previous year and the previous quarter. Investors and analysts may closely monitor the company’s financial results and market performance to assess the potential impact on NREF stock in the future.

Tags: NREF
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Wind Farms: How Strategic Acquisitions Amplify the Impact of Green Energy Players

Analyzing Short Interest Trends in Baker Hughes

Pickleball sports

Revolutionizing the Fan Experience MetLife Stadiums Cashless Payment Partnership with Shift4

Tech-Innovations

RBC Capital Analyst Upgrades Snowflake Price Target to 246

Recommended

Anticipating Navigator Holdings Quarterly Earnings Report Analysts Predict 030 EPS

2 years ago
Sandy Spring Stock

Sandy Spring Bancorp’s Final Chapter: A New Era Under Atlantic Union

3 months ago
Certara Stock

Certara Stock: Regulatory Milestone and Strong Fundamentals Fuel Recovery Hopes

6 months ago
Meta Stock

Meta Faces Mounting Pressure from Regulators and Strategic Shifts

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Navigating Change: Schnitzer Steel’s Digital and Structural Evolution

Akso Health Group Pivots to Oncology with Global Patient Initiative

Trending

Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

by Kennethcix
February 6, 2026
0

Deluxe Corporation is successfully shedding its legacy identity as a check-printing specialist. The company's strategic pivot toward...

Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026
Vir Biotechnology Stock

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

February 6, 2026
Tellurian Stock

Tellurian Acquisition Finalized as Woodside Takes Control

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Deluxe Stock Gains Momentum on Successful Fintech Transition
  • Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches
  • Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com